Loading clinical trials...
Loading clinical trials...
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Conditions
Interventions
Timolol nasal spray
Placebo nasal spray
Locations
1
France
Hospices Civils de Lyon - Hôpital Femme Mère Enfant / Service de génétique Clinique
Bron, France
Start Date
June 1, 2015
Primary Completion Date
November 1, 2017
Completion Date
January 29, 2018
Last Updated
August 8, 2025
NCT04194619
NCT00230620
NCT00230633
NCT04108052
NCT02157987
NCT00230659
Lead Sponsor
Hospices Civils de Lyon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions